COPD 2013: An Update on Treatment and Newly Approved Medications for Pharmacists

Journal of the American Pharmacists Association : JAPhA - United States
doi 10.1331/japha.2013.13535
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention for Newly Diagnosed and Treatment-Naive Atrial Fibrillation Patients: An Update Using 2013-2014 Data

Journal of managed care & specialty pharmacy
Health PolicyPharmacyPharmaceutical Science
2017English

COPD Update and New Guidance on Antibiotics for Exacerbations

Prescriber
Pharmacology
2019English

Effects of Food and Drug Administration-Approved Medications for Alzheimer’s Disease on Clinical Progression

Alzheimer's and Dementia
Molecular NeuroscienceGerontologyHealth PolicyDevelopmental NeuroscienceMental HealthEpidemiologyGeriatricsCellularPsychiatryNeurology
2012English

Savannah River Site Approved Site Treatment Plan, 2000 Annual Update

2000English

Systematic Review of Telemonitoring in COPD: An Update

Pneumonologia i Alergologia Polska
2015English

Primary Biliary Cholangitis: An Update on Treatment

Gastrointestinal Nursing
Surgical NursingMedicalSpecialized NursingAdvanced
2019English

Exercise-Induced Anaphylaxis: An Update on Diagnosis and Treatment

Current Allergy and Asthma Reports
ImmunologyPulmonaryAllergyRespiratory Medicine
2010English

Update December 2013

Lymphatic Research and Biology
Cardiovascular MedicineCardiology
2013English

Cemiplimab Approved for Treatment of CSCC

Cancer Discovery
Oncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy